In inflammatory bowel disease (IBD), which comprises two major diseases, an ulcerative colitis and Crohn’s disease, downregulation of miR-141-3p leads to the upregulation of its target CXCL12ß [40]. Here, CXCL12 is linked to inflammatory bowel disease.